Longeveron Inc
Change company Symbol lookup
Select an option...
LGVN Longeveron Inc
PPIH Perma-Pipe International Holdings Inc
DPDW Deep Down Inc
WOLF Wolfspeed Inc
PAVM PAVmed Inc
CNBP Cornerstone Bancorp Inc
UPS United Parcel Service Inc
RHHBY Roche Holding AG
EGP Eastgroup Properties Inc
PMT PennyMac Mortgage Investment Trust
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Longeveron Inc. is a clinical stage biotechnology company, which is developing cellular therapies for specific aging-related and life-threatening conditions. The Company's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors. It is sponsoring phase I and II clinical trials in various indications, such as aging frailty, Alzheimer's disease (AD), metabolic syndrome, acute respiratory distress syndrome (ARDS), and hypoplastic left heart syndrome (HLHS). It is evaluating Lomecel-B as a therapy for aging frailty and is being designed to reduce inflammation associated with aging frailty and to promote an anti-inflammatory state by releasing anti-inflammatory molecules, which can promote physiological restoration to a more normal state. The Company has completed two multicenter trials in the United States for aging frailty.

Closing Price
$7.65
Day's Change
-0.20 (-2.55%)
Bid
--
Ask
--
B/A Size
--
Day's High
8.20
Day's Low
7.43
Volume
(Below Average)
Volume:
207,473

10-day average volume:
250,800
207,473

Upcoming Events

LGVN's fiscal year ends in December
There are no upcoming events for LGVN

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
May 13, 2022Q1 2022 Earnings Release-$0.17-$0.24 to -$0.21--
March 11, 2022Q4 2021 Earnings Release-$0.20-$0.25 to -$0.25--

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.